Guillaume de Lartigue & team show treatment with semaglutide reduced eating/weight gain, and improved glucose tolerance and cognitive behavior in a BBS mouse model: buff.ly/4F0fcqZ
Guillaume de Lartigue & team show treatment with semaglutide reduced eating/weight gain, and improved glucose tolerance and cognitive behavior in a BBS mouse model: buff.ly/4F0fcqZ
Identifying GLP-1 receptor therapy as a first-in-class treatment for Bardet-Biedl syndrome—
Guillaume de Lartigue & team show treatment with semaglutide reduced eating/weight gain, and improved glucose tolerance and cognitive behavior in a BBS mouse model: buff.ly/4F0fcqZ
Identifying GLP-1 receptor therapy as a first-in-class treatment for Bardet-Biedl syndrome—
Guillaume de Lartigue & team show treatment with semaglutide reduced eating/weight gain, and improved glucose tolerance and cognitive behavior in a BBS mouse model: buff.ly/4F0fcqZ